🇰🇷 BLINATUMOMAB in South Korea

BLINATUMOMAB (BLINATUMOMAB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

BLINATUMOMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BLINATUMOMAB approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for BLINATUMOMAB in South Korea?

Marketing authorisation holder not available in our data.